Industry Program Terrace 2A
The 8th WoCoVA industry program. The program is the responsibility of the presenting company and has no relationship with WoCoVA. It will be industry symposia, product demonstrations or workshops organzed
Wednesday 17 April 2024
11:15 – 12:00
Terrace 2A
Symposium : Vascular access excellence, wherever the patient is: Strategies for improving patient care & reducing costs with outside hospital care
Chair: Stephen Church, Director Medical & Clinical Affairs, BD MDS, EMEA
A reflection on the challenges and benefits of an OPAT service in Swansea Bay Health Board – Frankie Thompson, Lead Nurse Vascular Access & OPAT, Swansea Bay University Hospital, Wales, UK
Humanization of care, a new era. Home-Vascular Access Service – Dr. Monica Pinto, Director S.C Rehabilitation Medicine IRCCS National Cancer Institute G Pascale Foundation, Naples, Italy
Healthcare provision is currently undergoing significant transformation due to several factors, including an aging population, rising prevalence of chronic diseases, resource constraints, and financial pressures. Governments and healthcare organizations are actively exploring new models for delivering care. One key focus area is shifting healthcare provision outside the traditional hospital-based acute care setting.
This symposium will spotlight two innovative approaches to healthcare delivery that leverage the expertise of hospital infusion: Outpatient Antimicrobial Therapy (OPAT): Initially implemented in the UK, OPAT is now gaining broader adoption across Europe, including examples in Switzerland and Germany. By allowing patients to receive antimicrobial treatment without the need to stay in hospital, OPAT improves patient outcomes and reduces strain on hospital resources.
Secondly, Supporting Patient Carers: Involves empowering patient caregivers to play a more active role in care, maintenance, and monitoring of the patient’s vascular access. Supporting them through technology to provide remote assistance for effective communication with the hospital team. By enabling patients to be managed at home, this approach enhances patient well-being, frees up hospital capacity, and contributes to overall cost savings in the healthcare system.
These innovations represent a positive shift toward patient-centred care and more efficient resource utilization.
OBJECTIVES:
1. To understand that vascular access plays an important role in managing patient care outside of the normal acute care hospital environment, which has advantages for the patient and the healthcare system.
2. How vascular access can be used in an outpatient setting to effectively delivery antimicrobial therapy.
3. How technology can help to empower, enable, and support care givers to provide vascular access management in the home.
12:15 – 13:15
Terrace 2A
Product demonstration: Hands-on course: Right line, Right Now!
Facilitators: Teleflex Clinical and Medical Affairs Team
Overview: This course is dedicated to empowering the vascular access clinician to increase device success through appropriate device selection and optimal procedural technique. Within this 1-hour hands-on practical course, the learner will have the opportunity to consolidate their ultrasound skills for assessment and needling, as well as explore insertion and maintenance concepts for PICCs and Midlines.
Please note: This is the same session repeated twice, to allow additional opportunities for attendance around the scientific program.
13:45- 14:45
Terrace 2A
Product demonstration: A new type of PICC and PICC insertian solution
At the Branden product demonstration we will present and show a new all-in-on PICC, which is made of polyurethane and with a check valve. Next to this we will show the EDUG system which includes a new ultrasound probe which is 2 in 1: both linar and convex.
16:30- 17:30
Terrace 2A
Product demonstration: Implementing best practice Vascular Access management
The importance of vascular access management and how the Vascular Access Team can help drive best practice
Thursday 18 April 2024
08:45 – 09:45
Terrace 2A
Product demonstration: Experience VYGON products through demo & hands-on
Join us for a dynamic presentation showcasing our complete vascular access solutions. You will experience hands-on demonstration of our products including :
– PPS® safety Huber needles enabling one-handed removal with a total needle body and tip protection and enabling easily positive pressure application upon removal
– Lifecath CT PICC Easy: Unique PICC line with proximal trimming couple with the extremely precise and versatile Pilot TLS IC-ECG system
– Smartmidline Mini-midline insertion with our compact and high image quality Vysion Andy wireless probe
10:00 – 11:00
Terrace 2A
Product demonstration: Enhancing catheter line placement outcomes by incorporating SecurePortIV®
SecurePortIV® (SPIV) is an evidence-based technology that seals the insertion site of all vascular access catheters, provides a microbial barrier, and comes with a > 8-log reduction against gram -, gram +, yeast, and fungi. In addition, SPIV has a 3.47 log-reduction and 99% immobilization of Candida Auris. SPIV secures the catheter, provides hemostasis, and may be used to improve dressing adherence.
Please join us for this informative session that will review the use of SecurePortIV® to provide additional benefits to your current practice for preventing VAD dislodgements, infections, and bleeding by considering the opportunity to incorporate SPIV into the standard of care across all VADs.
11:25 – 12:10
Terrace 2A
Symposium : Advances in Vascular Assess Technology: How technology can help you to improve patient care & experience
Chair: Servane Pelle, Associate Director Medical & Clinical Affairs BD MDS, EMEA
Strategies for preventing catheter related thrombosis in 2024 – Dr. Mauro Pittiruti, Surgeon, Catholic University Hospital, Rome, Italy
How Strong Collaboration Between Healthcare Professionals & Product Development Teams Improves Patient Care & Experience – Shayne Messerly, Director of Innovation, BD Medication Delivery Systems
BRIEF OVERVIEW:
Catheter-related thrombosis in vascular access is frequently encountered, yet the precise causes remain somewhat elusive due to the number of factors that may influence it. Catheter-related thrombosis often leads to premature catheter removal. Our first speaker will delve into the key factors contributing to these events, specifically how device choice and the insertion technique are crucial factors in minimising catheter-related thrombosis. Practical guidance on avoiding such complications will be provided.
Prizing winning author & futurist Arthur C. Clarke once wrote “The only way to discover the limits of possible is to go beyond them into the impossible”. ALL true innovation in the medical field, especially those in vascular access, have been a result of healthcare professionals working hand in hand with commercial product development teams. Our second speaker will present a case for even stronger collaboration and how open-mindedness to the “impossible” will improve patient care & experience. Past, present, and future innovations will be presented with the goal of driving excitement & energy around improved collaboration.
OBJECTIVES:
1. To understand the importance of the choice of the device in the prevention of catheter-related thrombosis
2. To understand the importance of the insertion technique in the prevention of catheter-related thrombosis
3. Showcase how open-mindedness to the impossible has changed the world
4. Drive energy and excitement around improved collaboration between healthcare professionals and commercial product development teams to improve patient care & experience
12:30 – 13:30
Terrace 2A
Product demonstration: Glubran Tiss for VADs management – a drop to protect
Expectation: At the GEM product demonstration you will learn how to use the glue (Glubran Tiss) in VADs management, the characteristics of the product, tips & tricks to apply it around the exit site of catheters. This by performing a practical session (hands-on) on skin pad simulators.
14:00 – 15:00
Terrace 2A
Product demonstration: Enabling technologies for PICC Placement
How ECG tip confirmation can help reduce procedure time and improve clinician’s workflow.
16:00 – 16:45
Terrace 2A
Symposium: Evidence-based needleless connector choice: adding to the CRBSI prevention bundle
Dr. Marcia Ryder, PhD, MS, RN, FNAP
Dr. Marcia Ryder, PhD, MS, RN, FNAP examines how the dramatic rise of catheter-related bloodstream infection (CRBSI) over the pandemic years has led clinicians to reconsider the impact of the choice of needleless connector (NC) on CRBSI risk. The research demonstrating the influence of NC design on intraluminal biofilm formation will be described. New research identifying a specific design technology that significantly reduces the risk of catheter-associated bloodstream infection and mortality at considerable cost savings will be presented.
Objectives:
At the end of this session, you will be able to:
1. Identify critical needleless design features that minimize biofilm formation and bacterial transfer.
2. Understand the importance of needleless connector design features and their impact on the risk of CRBSI, mortality, and cost.
3. Re-evaluate needleless connector choice in your healthcare setting.
Friday 19 April 2024
12:20 – 13:30
Terrace 2A
Product demonstration: Hands-on course: Right line, Right Now!
Facilitators: Teleflex Clinical and Medical Affairs Team
Overview: This course is dedicated to empowering the vascular access clinician to increase device success through appropriate device selection and optimal procedural technique. Within this 1-hour hands-on practical course, the learner will have the opportunity to consolidate their ultrasound skills for assessment and needling, as well as explore insertion and maintenance concepts for PICCs and Midlines.
Please note: This is the same session repeated twice, to allow additional opportunities for attendance around the scientific program.
